PPARG and fatty liver disease: Although these studies are restricted to non-alcoholic hepatic steatosis, we hypothesize that PPARγ and its downstream effector MGAT1 may play a role in alcohol-induced hepatic lipid accumulation if SIRT1 affects hepatic PPARγ during ethanol metabolism.